|
|
The Dermatology Market Outlook to 2011
CHAPTER 1: PATIENT POTENTIAL
- Summary
- Introduction
- Acne
- Overview
- Diagnosis, treatment and
management
- Epidemiology
- Forecast epidemiology
- Psoriasis
- Overview
- Diagnosis, treatment and
management
- Epidemiology
- Forecast epidemiology
- Infectious diseases of the
skin
- Overview
- Bacterial infections of
the skin
- Fungal infections of the
skin
- Viral infections of the
skin
- Diagnosis, treatment and
management
- Epidemiology
- Viral skin infections
- Fungal skin infections
- Bacterial skin infections
- Forecast epidemiology
- Viral skin infections
- Fungal skin infections
- Bacterial skin infections
- Dermatitis
- Overview
- Diagnosis, treatment and
management
- Epidemiology
- Forecast epidemiology
- Rosacea
- Overview
- Diagnosis, treatment and
management
- Epidemiology
- Forecast epidemiology
- Depression
- Regulation
- Governmental initiatives
- Advertising to children
- Labeling
- Taxation
- Conclusions
CHAPTER 2: GLOBAL MARKET ANALYSIS
- Summary
- Introduction
- Market analysis by country
- Licensing trends
- Market analysis by drug class
- Leading brands dynamics
- Key events in the dermatology
market
- Continued approvals for
biologic agents in the treatment of psoriasis
- Black box warnings for
Elidel and Protopic
- Safety concerns over
Roaccutane gain more traction
- Acne treatments
- Market analysis by drug
class
- Competitive dynamics of
acne treatments
- Leading acne treatment
brands
- Oral acne treatments
market analysis
- Market dynamics
- Key brands analysis
- Topical acne treatments
market analysis
- Market dynamics
- Key brands analysis
- Acne treatment sales
forecasts to 2011
- Psoriasis treatment
- Market analysis by drug
class
- Competitive dynamics of
psoriasis treatment classes
- Leading brands of
psoriasis treatments
- Market dynamics
- Key brands analysis
- Psoriasis treatments sales
forecasts to 2011
- Corticosteroid treatments
- Market analysis by drug
class
- Competitive dynamics of
corticosteroid treatment classes
- Leading brands of
corticosteroid treatments
- Corticosteroid treatments
market analysis
- Market dynamics
- Key brands analysis
- Corticosteroid treatment
sales forecasts to 2011
- Anti-infective treatments
- Market analysis by drug
class
- Leading brands of
anti-infective treatments
- Market dynamics
- Key brands analysis
- Anti-infective treatment
sales forecasts to 2011
- Other dermatologic treatments
- Leading brands of other
dermatologic treatments
- Key brands analysis
- Other dermatologic
treatments sales forecasts to 2011
- Total Therapeutic market sales
forecasts to 2011
CHAPTER 3: PIPELINE ANALYSIS
- Summary
- Introduction
- Key trends in R&D
- New mechanism of action
- Reformulations
- Combination drugs
- Biologics
- The therapeutic area pipeline
- Leading drugs in development
- Profiles of key pipeline
products
- Phase II compounds
- rambazole
- Phase III compounds
- Panaclar/BG-12
- CNTO 1275 interleukin
antagonist
- Drugs in registration
- Altabax (retapamulin)
- Desonate (desonide)
- Recently marketed drugs
- Humira (adalimumab)
- Oracea (doxycycline
extended release sub anti-microbial dose)
- Remicade (infliximab)
- Taclonex (calcipotriene/betamethasone)
- Ziana (clindamycin/tretinoin)
- Pipeline forecasts
- Factors affecting
forecasts
- Dermatology pipeline
forecasts
CHAPTER 4: COMPETITIVE LANDSCAPE
- Summary
- Introduction
- Company market shares
- Novartis
- Overview
- Sales focus by drug class
- Marketed product portfolio
- R&D pipeline analysis
- Strategic and growth
analysis
- Drivers of growth
- Resistors of growth
- GlaxoSmithKline
- Overview
- Sales focus by drug class
- Marketed product portfolio
- R&D pipeline analysis
- Strategic and growth
analysis
- Drivers of growth
- Resistors of growth
- Schering-Plough
- Overview
- Sales focus by drug class
- Marketed Product Portfolio
- R&D pipeline analysis
- Strategic and growth
analysis
|
